353 related articles for article (PubMed ID: 7569729)
1. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
[TBL] [Abstract][Full Text] [Related]
2. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
3. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
[TBL] [Abstract][Full Text] [Related]
4. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
5. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
[TBL] [Abstract][Full Text] [Related]
6. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
8. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
9. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of a urodilatin infusion in patients with liver cirrhosis, with and without ascites.
Carstens J; Greisen J; Jensen KT; Vilstrup H; Pedersen EB
J Am Soc Nephrol; 1998 Aug; 9(8):1489-98. PubMed ID: 9697672
[TBL] [Abstract][Full Text] [Related]
11. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
Nielsen CB; Pedersen EB
Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
[TBL] [Abstract][Full Text] [Related]
12. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
13. A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery.
de Lasson L; Hansen HE; Juhl B; Paaske WP; Pedersen EB
Eur J Vasc Endovasc Surg; 1995 Jul; 10(1):82-90. PubMed ID: 7633974
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide and exaggerated natriuresis during acute hypertonic volume expansion in essential hypertension.
Sørensen SS; Danielsen H; Amdisen A; Pedersen EB
J Hypertens; 1989 Jan; 7(1):21-9. PubMed ID: 2523419
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
Nielsen CB; Bech JN; Pedersen EB
Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
[TBL] [Abstract][Full Text] [Related]
16. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
Eiskjaer H; Sørensen SS; Danielsen H; Pedersen EB
J Hypertens; 1992 Sep; 10(9):1033-40. PubMed ID: 1328362
[TBL] [Abstract][Full Text] [Related]
17. Change in renal tubular sodium and water handling during progression of polycystic kidney disease: relationship to atrial natriuretic peptide.
Sørensen SS; Glud TK; Sørensen PJ; Amdisen A; Pedersen EB
Nephrol Dial Transplant; 1990; 5(4):247-57. PubMed ID: 2141389
[TBL] [Abstract][Full Text] [Related]
18. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
[TBL] [Abstract][Full Text] [Related]
19. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]